News
The RENEW Phase 2 trial will enroll up to 120 IPF patients with topline data expected in the first half of 2026 In the previously reported Phase 1b study, LTI-03 showed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback